Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort

被引：0
|
作者：
Benjamin Tan
Adnan Khattak
Enriqueta Felip
Karen Kelly
Patricia Rich
Ding Wang
Christoph Helwig
Isabelle Dussault
Laureen S. Ojalvo
Nicolas Isambert
机构：
[1] Washington University School of Medicine,Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO)
[2] Fiona Stanley Hospital,undefined
[3] IOB-Quiron,undefined
[4] UVic-UCC,undefined
[5] University of California Davis Comprehensive Cancer Center,undefined
[6] Cancer Treatment Centers of America,undefined
[7] Piedmont Healthcare,undefined
[8] Henry Ford Cancer Institute,undefined
[9] Merck KGaA,undefined
[10] EMD Serono Research & Development Institute,undefined
[11] Inc.,undefined
[12] An affiliate of Merck KGaA,undefined
[13] Poitiers University Hospital,undefined
来源：
Targeted Oncology | 2021年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：435 / 446
页数：11
相关论文
共 50 条
  • [1] Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
    Tan, Benjamin
    Khattak, Adnan
    Felip, Enriqueta
    Kelly, Karen
    Rich, Patricia
    Wang, Ding
    Helwig, Christoph
    Dussault, Isabelle
    Ojalvo, Laureen S.
    Isambert, Nicolas
    TARGETED ONCOLOGY, 2021, 16 (04) : 435 - 446
  • [2] Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia
    Lin, Chia-Chi
    Doi, Toshihiko
    Muro, Kei
    Hou, Ming-Mo
    Esaki, Taito
    Hara, Hiroki
    Chung, Hyun Cheol
    Helwig, Christoph
    Dussault, Isabelle
    Osada, Motonobu
    Kondo, Shunsuke
    TARGETED ONCOLOGY, 2021, 16 (04) : 447 - 459
  • [3] Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia
    Chia-Chi Lin
    Toshihiko Doi
    Kei Muro
    Ming-Mo Hou
    Taito Esaki
    Hiroki Hara
    Hyun Cheol Chung
    Christoph Helwig
    Isabelle Dussault
    Motonobu Osada
    Shunsuke Kondo
    Targeted Oncology, 2021, 16 : 447 - 459
  • [4] Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial
    Spira, Alexander
    Wertheim, Michael S.
    Kim, Edward J.
    Tan, Benjamin
    Lenz, Heinz-Josef
    Nikolinakos, Petros
    Rich, Patricia L.
    Jehl, Genevieve
    Machl, Andreas
    Ito, Rena
    Gulley, James L.
    Kopetz, Scott
    ONCOLOGIST, 2023, 28 (02): : E124 - E127
  • [5] Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1
    Vugmeyster, Yulia
    Wilkins, Justin
    Koenig, Andre
    El Bawab, Samer
    Dussault, Isabelle
    Ojalvo, Laureen S.
    De Banerjee, Samrita
    Klopp-Schulze, Lena
    Khandelwal, Akash
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 566 - 574
  • [6] Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
    Paz-Ares, Luis
    Kim, Tae Min
    Vicente, David
    Felip, Enriqueta
    Lee, Dae Ho
    Lee, Ki Hyeong
    Lin, Chia-Chi
    Jose Flor, Maria
    Di Nicola, Massimo
    Maria Alvarez, Rosa
    Dussault, Isabelle
    Helwig, Christoph
    Ojalvo, Laureen S.
    Gulley, James L.
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : 1210 - 1222
  • [7] Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-ß and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma
    Khasraw, Mustafa
    Weller, Michael
    Lorente, David
    Kolibaba, Kathryn
    Lee, Chee Khoon
    Gedye, Craig
    de La Fuente, Macarena, I
    Vicente, David
    Reardon, David A.
    Gan, Hui K.
    Scott, Andrew M.
    Dussault, Isabelle
    Helwig, Christoph
    Ojalvo, Laureen S.
    Gourmelon, Carole
    Groves, Morris
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [8] Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort
    Cho, Byoung Chul
    Daste, Amaury
    Ravaud, Alain
    Salas, Sebastien
    Isambert, Nicolas
    McClay, Edward
    Awada, Ahmad
    Borel, Christian
    Ojalvo, Laureen S.
    Helwig, Christoph
    Rolfe, P. Alexander
    Gulley, James L.
    Penel, Nicolas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [9] Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
    Strauss, Julius
    Gatti-Mays, Margaret E.
    Cho, Byoung Chul
    Hill, Andrew
    Salas, Sebastien
    McClay, Edward
    Redman, Jason M.
    Sater, Houssein A.
    Donahue, Renee N.
    Jochems, Caroline
    Lamping, Elizabeth
    Burmeister, Andrea
    Marte, Jennifer L.
    Cordes, Lisa M.
    Bilusic, Marijo
    Karzai, Fatima
    Ojalvo, Laureen S.
    Jehl, Genevieve
    Rolfe, P. Alexander
    Hinrichs, Christian S.
    Madan, Ravi A.
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [10] EVALUATION OF BINTRAFUSP ALFA, A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF-β AND PD-L1, IN CERVICAL CANCER: DATA FROM PHASE 1 AND PHASE 2 STUDIES
    Strauss, J.
    Braiteh, F.
    Calvo Aller, E.
    De Miguel, M.
    Cervantes, A.
    Edenfield, W. J.
    Li, T.
    Rasschaert, M. A.
    Park-Simon, T. W.
    Munoz, F. L.
    Paz-Ares, L.
    Spira, A.
    Jehl, G.
    Dussault, I.
    Ojalvo, L.
    Gulley, J.
    Allan, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A5 - A6
12345